You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Platinum salts

Showing 1 - 25 of 1,821
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immediate Hypersensitivity Reactions to Platinum Salts in

Recruiting
  • Drug Allergy
  • no intervention
  • Nancy, Vandoeuvre-Lès-Nancy, France
    CHRU Nancy
Jun 4, 2021

Breast Cancer After Ovarian Cancer During and/or After Therapy:

Recruiting
  • BRCA-Associated Breast Carcinoma
  • Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 9, 2023

Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Stage II and

Recruiting
  • Breast Cancer
  • Breast Cancer Stage II-III
  • Docetaxel- Carboplatin
  • Madrid, Spain
    Hospital Universitario Gregorio Marañon
Aug 24, 2021

PD1/PDL1 Inhibitors Treatment Duration in Patients With NSCLC

Recruiting
  • Non-small Cell Lung Cancer
  • Monza, Italy
    ASST-Monza Ospedale San Gerardo
Jun 9, 2022

Lung Cancer and Cancer of Digestive System Trial in Pierre-Bénite (INTERVIONNAL, CONTROL)

Completed
  • Lung Cancer and Cancer of Digestive System
  • INTERVIONNAL
  • CONTROL
  • Pierre-Bénite, France
    Centre Hospitalier Lyon Sud
May 27, 2021

Electronic Cigarette Use, Cigarette Smoking, Cigarette Use, Electronic Trial in Los Angeles (E-cigarette)

Completed
  • Electronic Cigarette Use
  • +3 more
  • E-cigarette
  • Los Angeles, California
    University of Southern California
Jul 14, 2023

Nsclc Trial in Lille (procedure, drug, biological)

Terminated
  • Nsclc
  • Clinical exam
  • +5 more
  • Lille, France
  • +1 more
Oct 14, 2021

Advanced Biliary Tract Carcinoma Trial in France (Durvalumab, Tremelimumab)

Recruiting
  • Advanced Biliary Tract Carcinoma
  • Besançon, France
  • +27 more
Jan 26, 2021

Healthy Trial in Saint-Herblain (5-MTHF glucosamine salt, 5-MTHF calcium salt 1, 5-MTHF calcium salt 2)

Recruiting
  • Healthy
  • 5-MTHF glucosamine salt
  • +2 more
  • Saint-Herblain, France
    Biofortis
Jan 31, 2023

ADHD Trial (Concerta, Adderall-XR)

Not yet recruiting
  • ADHD
  • (no location specified)
Dec 6, 2022

NSCLC (NSCLC) Trial (Sotorasib, Pembrolizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • (no location specified)
Jun 26, 2023

Iron Deficiency, Iron Deficiency Anemia Trial in Kotri (Ferrous sulphate, Ferric pyrophosphate, Ferric sodium pyrophosphate)

Recruiting
  • Iron Deficiency
  • Iron Deficiency Anemia
  • Ferrous sulphate
  • +3 more
  • Kotri, Sindh, Pakistan
    Bilawal Medical College Hospital
Aug 10, 2023

Patient Activation Trial in Moscow (PanTrek)

Not yet recruiting
  • Patient Activation
  • PanTrek
  • Moscow, Russian Federation
    Laboratory of psychopharmacology Research center of mental healt
Jan 10, 2023

Platinum-resistant Ovarian Cancer

Not yet recruiting
  • Ovarian Cancer
  • pegylated liposomal doxorubicin
  • (no location specified)
Aug 2, 2023

Triple Negative Breast Cancer Trial in Dhaka (Doxorubicin, Cyclophosphamide, Paclitaxel)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
May 24, 2023

Ovarian Cancer Trial (Aribulin;carboplatin;bevacizumab)

Not yet recruiting
  • Ovarian Cancer
  • (no location specified)
Jul 20, 2023

Cervical Cancer Trial in Wuhan (Recombinant humanized anti-PD-1 mAb injection, Cisplatin, Bevacizumab Injection)

Not yet recruiting
  • Cervical Cancer
  • Recombinant humanized anti-PD-1 monoclonal antibody injection
  • +4 more
  • Wuhan, Hubei, China
    Tongji Hospital affiliated to Tongji Medical College of Huazhong
Nov 3, 2023

Small Cell Lung Carcinoma Trial in Worldwide (Pembrolizumab/Vibostolimab Co-Formulation, Saline , Etoposide)

Recruiting
  • Small Cell Lung Carcinoma
  • Pembrolizumab/Vibostolimab Co-Formulation
  • +5 more
  • Los Angeles, California
  • +122 more
Jan 27, 2023

Oesophageal Reflux, Gastric Reflux, Hyperactivity; Stomach Trial in Barcelona (Antacid, Control)

Active, not recruiting
  • Oesophageal Reflux
  • +2 more
  • Antacid
  • Control
  • Barcelona, Spain
    Oriol Armengol
Aug 1, 2022

Non-Small-Cell Lung Carcinoma Trial in Japan (biological, drug, dietary supplement)

Active, not recruiting
Has Results
  • Non-Small-Cell Lung Carcinoma
  • Pembrolizumab 200 mg
  • +7 more
  • Nagoya, Aichi, Japan
  • +9 more
Jan 23, 2023

GSTP1 and Other Gene Polymorphisms With Platinum-induced

Not yet recruiting
  • Non-small Cell Lung Cancer
  • GSTP1 A313G （AA）
  • (no location specified)
Nov 16, 2023

NSCLC Trial in Tianjing (Envalfolimab subcutaneously injected+Platinum-based doublet chemo intravenous injection,

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Envalfolimab subcutaneously injected+Platinum-based doublet chemotherapy intravenous injection
  • placebo subcutaneously injected +Platinum-based doublet chemotherapy intravenous injection
  • Tianjing, Tianjin, China
    Tianjin cancer hospital
Nov 3, 2023

Non-squamous Non-small-cell Lung Cancer Trial in Hangzhou (Tusamitamab ravtansine+Sintilimab+Carboplatin or

Not yet recruiting
  • Non-squamous Non-small-cell Lung Cancer
  • Tusamitamab ravtansine+Sintilimab+Carboplatin or Cisplatin+Pemetrexed
  • +2 more
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
May 5, 2023

Ovarian Cancer Recurrent Trial (Fluzopril Combined With Apatinib)

Not yet recruiting
  • Ovarian Cancer Recurrent
  • Fluzopril Combined With Apatinib
  • (no location specified)
Oct 22, 2023

Metastatic Non-squamous Non Small Cell Lung Cancer Trial in Worldwide (Cosibelimab, Cisplatin, Carboplatin)

Active, not recruiting
  • Metastatic Non-squamous Non Small Cell Lung Cancer
  • Vitória, Brazil
  • +21 more
Aug 17, 2022